India to United States: Capecitabine Export Trade Route
India has recorded 293 verified shipments of Capecitabine exported to United States, representing a combined trade value of $58.3M USD. This corridor is served by 10 active Indian exporters, with an average shipment value of $199.0K USD. The leading Indian exporter is MANKIND PHARMA LIMITED, which accounts for 54% of total export value with 58 shipments worth $31.2M USD. On the buying side, LIFESTAR PHARMA LLC. is the largest importer in United States with $30.2M USD in purchases. The top 3 suppliers — MANKIND PHARMA LIMITED, ALKEM LABORATORIES LIMITED, MSN LABORATORIES PRIVATE LIMITED — together control 92% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Capecitabine corridor is one of India's established pharmaceutical export routes, with 293 shipments documented worth a combined $58.3M USD. The route is dominated by MANKIND PHARMA LIMITED, which alone accounts for roughly 54% of all export value, reflecting the consolidated nature of India's capecitabine manufacturing sector.
Across 10 active suppliers, the average shipment value stands at $199.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 22.0%, placing it at rank #20 among India's top capecitabine export destinations globally.
On the import side, key buyers of Indian capecitabine in United States include LIFESTAR PHARMA LLC., ASCEND LABORATORIES LLC, NOVADOZ PHARMACEUTICALS LLC and 25 others. LIFESTAR PHARMA LLC. is the single largest importer with 10 shipments valued at $30.2M USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portHYDERABAD AIR
Market Position
- Global rank#20
- Annual growth+22.0%
- Demand growth+20.5%
- Regulatory ease66/100
Top 10 Indian Capecitabine Exporters to United States
Showing top 10 of 10 Indian suppliers exporting Capecitabine to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MANKIND PHARMA LIMITED Avg $538.5K per shipment | 58 | $31.2M | 53.6% |
| 2 | ALKEM LABORATORIES LIMITED Avg $931.0K per shipment | 20 | $18.6M | 31.9% |
| 3 | MSN LABORATORIES PRIVATE LIMITED Avg $25.3K per shipment | 148 | $3.7M | 6.4% |
| 4 | EUGIA PHARMA SPECIALITIES LIMITED Avg $94.9K per shipment | 37 | $3.5M | 6.0% |
| 5 | DR REDDYS LABORATORIES LIMITED Avg $83.9K per shipment | 7 | $587.4K | 1.0% |
| 6 | ALKEM LABORATORIES LTD Avg $211.2K per shipment | 1 | $211.2K | 0.4% |
| 7 | INTAS PHARMACEUTICALS LIMITED Avg $10.8K per shipment | 18 | $195.1K | 0.3% |
| 8 | DR REDDY S LABORATORIES LIMITED Avg $102.5K per shipment | 1 | $102.5K | 0.2% |
| 9 | AURIGENE PHARMACEUTICAL SERVICES LIMITED Avg $97.9K per shipment | 1 | $97.9K | 0.2% |
| 10 | ALLMPUS LABORATORIES PRIVATE LIMITED Avg $203 per shipment | 2 | $406 | 0.0% |
This table shows the top 10 of 10 Indian companies exporting capecitabine to United States, ranked by total trade value. The listed exporters are: MANKIND PHARMA LIMITED, ALKEM LABORATORIES LIMITED, MSN LABORATORIES PRIVATE LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, DR REDDYS LABORATORIES LIMITED, ALKEM LABORATORIES LTD, INTAS PHARMACEUTICALS LIMITED, DR REDDY S LABORATORIES LIMITED, AURIGENE PHARMACEUTICAL SERVICES LIMITED, ALLMPUS LABORATORIES PRIVATE LIMITED. MANKIND PHARMA LIMITED is the dominant supplier with 58 shipments worth $31.2M USD, giving it a 54% market share. The top 3 suppliers together account for 92% of the total trade value on this route.
Top 10 Capecitabine Importers in United States
Showing top 10 of 28 known buyers in United States receiving Capecitabine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian capecitabine in United States include LIFESTAR PHARMA LLC., ASCEND LABORATORIES LLC, NOVADOZ PHARMACEUTICALS LLC, AUROBINDO PHARMA USA., INC,, AUROBINDO PHARMA USA INC, among 28 total buyers. The largest importer is LIFESTAR PHARMA LLC., accounting for $30.2M USD across 10 shipments — representing 52% of all capecitabine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LIFESTAR PHARMA LLC. | 10 | $30.2M | 51.8% |
| 2 | ASCEND LABORATORIES LLC | 11 | $18.2M | 31.2% |
| 3 | NOVADOZ PHARMACEUTICALS LLC | 103 | $2.7M | 4.7% |
| 4 | AUROBINDO PHARMA USA., INC, | 14 | $1.5M | 2.6% |
| 5 | AUROBINDO PHARMA USA INC | 7 | $1.3M | 2.2% |
| 6 | TO THE ORDER OF | 44 | $950.0K | 1.6% |
| 7 | LIFESTAR PHARMA LLC | 40 | $844.8K | 1.4% |
| 8 | DR REDDYS LABORATORIES INC | 6 | $485.0K | 0.8% |
| 9 | AUROBINDO PHARMA USA., INC | 3 | $409.4K | 0.7% |
| 10 | ASCEND LABORATORIES,LLC | 6 | $392.2K | 0.7% |
Showing top 10 of 28 Capecitabine importers in United States on this route.
Top 10 Capecitabine Formulations Imported by United States
Showing top 10 of 174 product formulations shipped on the India to United States Capecitabine route, ranked by trade value
United States imports a wide range of capecitabine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CAPECITABINE TABLETS USP 500MG (EACH TABCONT. CAPECITABINE USP 500MG) [5872 PACK X 120'S] (BATCH NO. 23123828, 23123829 — accounts for $17.6M USD across 1 shipments. There are 174 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CAPECITABINE TABLETS USP 500MG (EACH TABCONT. CAPECITABINE USP 500MG) [5872 PACK X 120'S] (BATCH NO. 23123828, 23123829 | 1 | $17.6M | 30.3% |
| 2 | CAPECITABINE TABLETS 500MG [PACK: 888 X120'S] (BATCH NO. RCTH10323A MFG.DT. 11/2023; EXP.DT. 10/2026) | 1 | $3.1M | 5.3% |
| 3 | CAPECITABINE TABLETS 500MG [PACK: 876 X120'S] (BATCH NO. RCTH10423A MFG.DT. 11/2023; EXP.DT. 10/2026) | 1 | $3.0M | 5.2% |
| 4 | CAPECITABINE TABLETS 500MG [PACK: 876 X120'S] (BATCH NO. RCTH10223A MFG.DT. 11/2023; EXP.DT. 10/2026) | 1 | $3.0M | 5.2% |
| 5 | CAPECITABINE TABLETS 500MG [PACK: 876 X120'S] (BATCH NO. RCTH10023A MFG.DT. 11/2023; EXP.DT. 10/2026) | 1 | $3.0M | 5.2% |
| 6 | CAPECITABINE TABLETS 500MG [PACK: 876 X120'S] (BATCH NO. RCTH9923A MFG.DT. 11/2023; EXP.DT. 10/2026) | 1 | $3.0M | 5.2% |
| 7 | CAPECITABINE TABLETS 500MG [PACK: 864 X120'S] (BATCH NO. RCTH9623A MFG.DT. 10/2023; EXP.DT. 09/2026) | 1 | $3.0M | 5.1% |
| 8 | CAPECITABINE TABLETS 500MG [PACK: 864 X120'S] (BATCH NO. RCTH9423A MFG.DT. 10/2023; EXP.DT. 09/2026) | 1 | $3.0M | 5.1% |
| 9 | CAPECITABINE TABLETS 500MG [PACK: 864 X120'S] (BATCH NO. RCTH9123A MFG.DT. 10/2023; EXP.DT. 09/2026) | 1 | $3.0M | 5.1% |
| 10 | CAPECITABINE TABLETS 500MG [PACK: 864 X120'S] (BATCH NO. RCTH9023A MFG.DT. 10/2023; EXP.DT. 09/2026) | 1 | $3.0M | 5.1% |
Showing top 10 of 174 Capecitabine formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 66% sea for bulk, 16% air for urgent orders.
Top Ports of Origin
HYDERABAD AIR handles the highest volume with 88 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's capecitabine exports to United States are driven primarily by a handful of large-scale manufacturers. MANKIND PHARMA LIMITED with 58 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MANKIND PHARMA LIMITED, ALKEM LABORATORIES LIMITED, MSN LABORATORIES PRIVATE LIMITED — together account for 92% of total trade value on this route. The average shipment value of $199.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as capecitabine tablets 500mg [pack: 888 x120's] (batch no. rcth10323a mfg.dt. 11/2023; exp.dt. 10/2026) and capecitabine tablets 500mg [pack: 876 x120's] (batch no. rcth10423a mfg.dt. 11/2023; exp.dt. 10/2026), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, LIFESTAR PHARMA LLC. is the largest importer with 10 shipments worth $30.2M USD — representing 52% of all capecitabine imports from India on this route. A total of 28 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $58.3M
- Avg. Shipment
- $199.0K
- Suppliers
- 10
- Buyers
- 28
- Transit (Sea)
- ~24 days
- Annual Growth
- +22.0%
Related Analysis
Reverse Direction
United States → India — Capecitabine (Import)Other Capecitabine Routes
Unlock the Full India to United States Capecitabine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 293 shipments on this route.
Frequently Asked Questions — India to United States Capecitabine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Capecitabine to United States?
The leading Indian exporters of Capecitabine to United States are MANKIND PHARMA LIMITED, ALKEM LABORATORIES LIMITED, MSN LABORATORIES PRIVATE LIMITED. MANKIND PHARMA LIMITED holds the largest market share at approximately 54% of total trade value on this route.
Q What is the total value of Capecitabine exports from India to United States?
India exports Capecitabine to United States worth approximately $58.3M USD across 293 recorded shipments. The average value per shipment is $199.0K USD.
Q Which ports does India use to ship Capecitabine to United States?
The most active port of origin is HYDERABAD AIR with 88 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 66% of shipments going by sea and 16% by air.
Q How long does shipping take from India to United States for Capecitabine?
The average transit time for Capecitabine shipments from India to United States is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Capecitabine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 22.0% with demand growth tracking at 20.5%. The route is ranked #20 among India's top Capecitabine export destinations globally.
Q How many suppliers are active on the India to United States Capecitabine route?
There are currently 10 active Indian suppliers exporting Capecitabine to United States. The market is moderately concentrated with MANKIND PHARMA LIMITED accounting for 54% of total shipment value.
Q Who are the main importers of Capecitabine from India in United States?
The leading importers of Indian Capecitabine in United States include LIFESTAR PHARMA LLC., ASCEND LABORATORIES LLC, NOVADOZ PHARMACEUTICALS LLC, AUROBINDO PHARMA USA., INC,, AUROBINDO PHARMA USA INC. LIFESTAR PHARMA LLC. is the largest buyer with 10 shipments worth $30.2M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Capecitabine.
- 2.Supplier/Buyer Matching: 10 Indian exporters and 28 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 293 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
293 Verified Shipments
10 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists